Complement C1-inhibitor expression in Alzheimer's disease

Acta Neuropathologica

Volumn 96, Issue 3, 1998, Pages 287-296

  Veerhuis, R ^a,c   Janssen, I ^a   Hoozemans, J J M ^a   De Groot, C J A ^a   Hack, C E ^b   Eikelenboom, P ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Astrocytes; C1 esterase inhibitor; Complement; RNA in situ hybridization

Indexed keywords

AMYLOID; COMPLEMENT COMPONENT C1S INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MESSENGER RNA SYNTHESIS; NERVE DEGENERATION; NEURITE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CELLS, CULTURED; COMPLEMENT C1 INACTIVATOR PROTEINS; FEMALE; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RNA PROBES; RNA, MESSENGER; TEMPORAL LOBE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031691401     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050896     Document Type: Article

References (45)

1. Akiyama H, Ikeda K, Kondo H, McGeer PL (1992) Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett 146: 152-154
2. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601
3. Aulak KS, Donaldson VH, Coutinho M, Davis AE III (1993) C1-Inhibitor: structure/function and the biologic role. Behring Inst Mitt 93: 204-213
4. Balmforth AJ, Ball SG, Freshney RI, Graham DI, McNamee HB, Vaughan PF (1986) D-1 Dopaminergic and β-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM. J Neurochem 47: 715-719
5. Barnum SR (1995) Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6: 132-146
6. 2. Brain Res 777: 210-218
7. Bock SC, Skriver K, Nielsen E, Thogersen HC, Wiman B, Donaldson VH, Eddy RL, Marrinan J, Radziejewska E, Huber R, Shows TB, Magnusson S (1986) Human C1 inhibitor: primary structure, cDNA cloning and chromosomal localization. Biochemistry 25: 4292-4301
8. Brands JHGM, Maassen JA, Hemert FJ van, Amons R, Möller W (1986) The primary structure of the a subunit of human elongation-factor 1. Structural aspects of guanidine-nucleotide-binding sites. Eur J Biochem 155: 167-171
9. Carter PE, Duponchel C, Tosi M, Fothergill JE (1991) Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements. Eur J Biochem 197: 301-308
10. De Groot CJA, Langeveld CH, Jongenelen CAM, Montagne EJ, Van der Valk P, Dijkstra CD (1997) Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J Neurosci Res 49: 342-354
11. De Smet BJGL, De Boer J-P, Agterberg J, Rigter G, Bleeker WK, Hack CE (1994) Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-Inhibitor in rats. Blood 81: 56-61
12. Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56: 321-339
13. Eikelenboom P, Stam FC (1982) Immunoglobulins and complement factors in senile plaques. An histochemical study. Acta Neuropathol (Berl) 57: 239-242
14. Eikelenboom P, Veerhuis R (1996) The role of complement and acivated microglia in the pathogenesis of Alzheimer's disease. Neurobiol Aging 17: 673-680
15. Eikelenboom P, Hack CE, Rozemuller JM, Stam FC (1989) Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch [B] 56: 259-262
16. Eikelenboom P, Rozemuller JM, Kraal G, Stam FC, McBride PA, Fraser H (1991) Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch [B] 60: 329-336
17. Eldering E, Nuijens JH, Hack CE (1988) Expression of functional human C1 Inhibitor in COS cells. J Biol Chem 263: 11776-11779
18. Gasque P, Ischenko A, Legoedec J, Mauger C, Schouft M-T, Fontaine M (1993) Expression of the complement classical pathway by human glioma in culture. J Biol Chem 268: 25068-25074
19. Gasque P, Thomas A, Fontaine M, Morgan BP (1996) Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. J Neuroimmunol 66: 29-40
20. Ishii T, Haga S (1984) Immuno-electron microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol (Berl) 63: 296-300
21. Jiwa NM, Kanavaros P, Valk P van der, Walboomers JMM, Horstman A, Vos W, Mullink H, Meijer CJLM (1993) Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J Clin Pathol 46: 211-217
22. Johnson SA, Lampert-Ettchells M, Pasinetti GM, Rozovsky I, Finch CE (1992) Complement mRNA in the mammalian brain: reponses to Alzheimer's disease and experimental lesioning. Neurobiol Aging 13: 641-648
23. Katz Y, Strunk RC (1989) Synthesis and regulation of C1 inhibitor in human skin fibroblasts. J Immunol 142: 2041-2045
24. Kiefer R, Kreutzberg GW (1990) Gamma interferon-like immunoreactivity in the rat nervous system. Neuroscience 37: 725-734
25. Lampert-Etchells M, Pasinetti GM, Finch CE, Johnson SA (1993) Regional localization of cells containing complement C1q and C4 mRNAs in the frontal cortex during Alzheimer's disease. Neurodegeneration 2: 111-121
26. Lappin DF, Guc DD, Hill A, McShane T, Whaley K (1992) Effect of interferon-γ on complement gene expression in different cell types. Biochem J 281: 437-442
27. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Immune system response in Alzheimer's disease. Can J Neurol Sci 16: 516-527
28. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR (1984) Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 12: 7035-7056
29. Nuijens JH, Huijbregts CCM, Mierlo GM van, Hack CE (1987) Inactivation of C1 inhibitor by proteases: demonstration by a monoclonal antibody of a neodeterminant on inactivated, non-complexed C1 inhibitor. Immunology 61: 387-389
30. Olsson T, Kelic S, Edlund C, Bakhiet M, Höjeberg B, Meide PH van der, Ljungdahl Å, Kristensson K (1994) Neuronal interferon-γ immunoreactive molecule: bioactivities and purification. Eur J Immunol 24: 308-314
31. Pasinetti GM, Johnson SA, Rozovsky I, Lampert-Etchells M, Morgan DG, Gordon MN, Willoughby D, Finch CE (1992) Complement C1qB and C4 mRNAs reponses to lesioning in rat brain. Exp Neurol 118: 117-125
32. Pontèn J, Westermark B (1978) Properties of human malignant glioma cells in vitro. Med Biol 56: 184-193
33. Raap AK, Corput MP van de, Vervenne RA, Gijlswijk RP van, Tanke HJ, Wiegant J (1995) Ultra-sensitive FISH using peroxidase-mediated deposition of biotin-or fluorochrome tyramides. Hum Mol Genet 4: 539-534
34. Rogers J, Cooper R, Webster S, Schultz J McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I (1992) Complement activation by β-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 89: 10016-10020
35. Rozemuller JM, Eikelenboom P, Pals ST, Stam, FC (1989) Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci Lett 101: 288-292
36. Rozovsky I, Morgan TE, Willoughby DA, Dugich-Djordjevich MM, Pasinetti GM, Johnson SA, Finch CE (1994) Selective expression of clusterin (SGP-2) and complement C1q and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 62: 741-758
37. Schmaier AH, Murray SC, Ghashyam DH, Farber A, Kuo A, McCrae K, Cines DB (1989) Synthesis and expression of C1 inhibitor by human umbilical vein endothelial cells. J Biol Chem 264: 18173-18179
38. Tosi M (1993) Molecular genetics of C1-inhibitor and hereditary angiooedema. In: Whaley K, Loos M (eds) Complement in health and disease, 2nd edn. Kluwer, London, pp 245-267
39. Veerhuis R, Van der Valk P, Janssen I, Zhan S-S, Van Nostrand WE, Eikelenboom P (1995) Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3. Virchow Arch 426: 603-610
40. Veerhuis R, Janssen I, Hack CE, Eikelenboom P (1996) Early complement components in Alzheimer's disease brains. Acta Neuropathol 91: 53-60
41. Walker DG, McGeer PL (1992) Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Mol Brain Res 14: 109-116
42. Walker DG, Yasuhara O, Patston PA, McGeer EG, McGeer PL (1995) Complement C1 inhibitor is produced by human brain tissue and is cleaved in Alzheimer disease. Brain Res 675: 75-82
43. Yasuhara O, Walker DG, McGeer PL (1994) Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease. Brain Res 654: 234-240
44. Zahedi K, Prada AE, Davis AE III (1994) Transcriptional regulation of the C1 inhibitor gene by γ-interferon. J Biol Chem 269: 9669-9674
45. Zuraw BL, Lotz M (1990) Regulation of the hepatic synthesis of C1 inhibitor by the hepatocyte stimulating factors interleukin 6 and interferon γ. J Biol Chem 365: 12664-12670